AKT1 and urinary bladder cancer: found that U11 may be involved in the regulation of gene expression in bladder cancer cells, which can alter gene expression by affecting the PI3K-Akt signaling pathway and may be a potential biomarker for the clinical diagnosis and treatment of bladder cancer (28).